Ipca Laboratories Ltd.

NSE: IPCALAB | BSE: 524494 | ISIN: INE571A01038 | Industry: Pharmaceuticals
| Expensive Performer
1446.7500 -6.25 (-0.43%)
NSE Mar 25, 2025 15:31 PM
Volume: 227.6K
 

1446.75
-0.43%
Sharekhan
Ipca Laboratories Limited’s (Ipca) earnings came above our estimates, as sales grew 32.9% y-o-y to Rs. 2,092 crore. Sales growth was led by 11.6% y-o-y growth in domestic branded formulations.
Ipca Laboratories Ltd. has an average target of 1815.00 from 3 brokers.
More from Ipca Laboratories Ltd.
Recommended